Cargando…
Aging Increases Hippocampal DUSP2 by a Membrane Cholesterol Loss-Mediated RTK/p38MAPK Activation Mechanism
Numerous studies suggest that the increased activity of p38MAPK plays an important role in the abnormal immune and inflammatory response observed in the course of neurodegenerative diseases such as Alzheimer's disease. On the other hand, high levels of p38MAPK are present in the brain during no...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603139/ https://www.ncbi.nlm.nih.gov/pubmed/31293510 http://dx.doi.org/10.3389/fneur.2019.00675 |
_version_ | 1783431457325187072 |
---|---|
author | Martín-Segura, Adrián Casadomé-Perales, Álvaro Fazzari, Pietro Mas, José Manuel Artigas, Laura Valls, Raquel Nebreda, Angel R. Dotti, Carlos G. |
author_facet | Martín-Segura, Adrián Casadomé-Perales, Álvaro Fazzari, Pietro Mas, José Manuel Artigas, Laura Valls, Raquel Nebreda, Angel R. Dotti, Carlos G. |
author_sort | Martín-Segura, Adrián |
collection | PubMed |
description | Numerous studies suggest that the increased activity of p38MAPK plays an important role in the abnormal immune and inflammatory response observed in the course of neurodegenerative diseases such as Alzheimer's disease. On the other hand, high levels of p38MAPK are present in the brain during normal aging, suggesting the existence of mechanisms that keep the p38MAPK-regulated pro-inflammatory activity within physiological limits. In this study, we show that high p38MAPK activity in the hippocampus of old mice is in part due to the reduction in membrane cholesterol that constitutively occurs in the aging brain. Mechanistically, membrane cholesterol reduction increases p38MAPK activity through the stimulation of a subset of tyrosine kinase receptors (RTKs). In turn, activated p38MAPK increases the expression and activity of the phosphatase DUSP2, which is known to reduce the activity of different MAPKs, including p38MAPK. These results suggest that the loss of membrane cholesterol that constitutively occurs with age takes part in a negative-feedback loop that keeps p38MAPK activity levels within physiological range. Thus, conditions that increase p38MAPK activity such as cellular stressors or that inhibit DUSP2 will amplify inflammatory activity with its consequent deleterious functional changes. |
format | Online Article Text |
id | pubmed-6603139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66031392019-07-10 Aging Increases Hippocampal DUSP2 by a Membrane Cholesterol Loss-Mediated RTK/p38MAPK Activation Mechanism Martín-Segura, Adrián Casadomé-Perales, Álvaro Fazzari, Pietro Mas, José Manuel Artigas, Laura Valls, Raquel Nebreda, Angel R. Dotti, Carlos G. Front Neurol Neurology Numerous studies suggest that the increased activity of p38MAPK plays an important role in the abnormal immune and inflammatory response observed in the course of neurodegenerative diseases such as Alzheimer's disease. On the other hand, high levels of p38MAPK are present in the brain during normal aging, suggesting the existence of mechanisms that keep the p38MAPK-regulated pro-inflammatory activity within physiological limits. In this study, we show that high p38MAPK activity in the hippocampus of old mice is in part due to the reduction in membrane cholesterol that constitutively occurs in the aging brain. Mechanistically, membrane cholesterol reduction increases p38MAPK activity through the stimulation of a subset of tyrosine kinase receptors (RTKs). In turn, activated p38MAPK increases the expression and activity of the phosphatase DUSP2, which is known to reduce the activity of different MAPKs, including p38MAPK. These results suggest that the loss of membrane cholesterol that constitutively occurs with age takes part in a negative-feedback loop that keeps p38MAPK activity levels within physiological range. Thus, conditions that increase p38MAPK activity such as cellular stressors or that inhibit DUSP2 will amplify inflammatory activity with its consequent deleterious functional changes. Frontiers Media S.A. 2019-06-25 /pmc/articles/PMC6603139/ /pubmed/31293510 http://dx.doi.org/10.3389/fneur.2019.00675 Text en Copyright © 2019 Martín-Segura, Casadomé-Perales, Fazzari, Mas, Artigas, Valls, Nebreda and Dotti. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Martín-Segura, Adrián Casadomé-Perales, Álvaro Fazzari, Pietro Mas, José Manuel Artigas, Laura Valls, Raquel Nebreda, Angel R. Dotti, Carlos G. Aging Increases Hippocampal DUSP2 by a Membrane Cholesterol Loss-Mediated RTK/p38MAPK Activation Mechanism |
title | Aging Increases Hippocampal DUSP2 by a Membrane Cholesterol Loss-Mediated RTK/p38MAPK Activation Mechanism |
title_full | Aging Increases Hippocampal DUSP2 by a Membrane Cholesterol Loss-Mediated RTK/p38MAPK Activation Mechanism |
title_fullStr | Aging Increases Hippocampal DUSP2 by a Membrane Cholesterol Loss-Mediated RTK/p38MAPK Activation Mechanism |
title_full_unstemmed | Aging Increases Hippocampal DUSP2 by a Membrane Cholesterol Loss-Mediated RTK/p38MAPK Activation Mechanism |
title_short | Aging Increases Hippocampal DUSP2 by a Membrane Cholesterol Loss-Mediated RTK/p38MAPK Activation Mechanism |
title_sort | aging increases hippocampal dusp2 by a membrane cholesterol loss-mediated rtk/p38mapk activation mechanism |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603139/ https://www.ncbi.nlm.nih.gov/pubmed/31293510 http://dx.doi.org/10.3389/fneur.2019.00675 |
work_keys_str_mv | AT martinseguraadrian agingincreaseshippocampaldusp2byamembranecholesterollossmediatedrtkp38mapkactivationmechanism AT casadomeperalesalvaro agingincreaseshippocampaldusp2byamembranecholesterollossmediatedrtkp38mapkactivationmechanism AT fazzaripietro agingincreaseshippocampaldusp2byamembranecholesterollossmediatedrtkp38mapkactivationmechanism AT masjosemanuel agingincreaseshippocampaldusp2byamembranecholesterollossmediatedrtkp38mapkactivationmechanism AT artigaslaura agingincreaseshippocampaldusp2byamembranecholesterollossmediatedrtkp38mapkactivationmechanism AT vallsraquel agingincreaseshippocampaldusp2byamembranecholesterollossmediatedrtkp38mapkactivationmechanism AT nebredaangelr agingincreaseshippocampaldusp2byamembranecholesterollossmediatedrtkp38mapkactivationmechanism AT dotticarlosg agingincreaseshippocampaldusp2byamembranecholesterollossmediatedrtkp38mapkactivationmechanism |